Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VALSARTAN USP (PROCESS II), with a corresponding US DMF Number 23491.
Remarkably, this DMF maintains an Active status since its submission on January 22, 2010, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 15, 2013, and payment made on November 23, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II